Bio-Rad Laboratories, Inc. BIO.B Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s equity method investments?
- Bio-Rad Laboratories, Inc. (BIO.B) reported equity method investments of $23.7M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s equity method investments changed year-over-year?
- Bio-Rad Laboratories, Inc.'s equity method investments increased by 3.0% year-over-year, from $23M to $23.7M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s equity method investments?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s equity method investments has grown at a -70.1% compound annual growth rate (CAGR), from $9.56B to $23M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.